We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
-8.17%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$218M
AUM Growth
-$19.5M
Cap. Flow
+$3.51M
Cap. Flow %
1.61%
Top 10 Hldgs %
4.42%
Holding
1,001
New
307
Increased
177
Reduced
167
Closed
349

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$934K
2
MASI
Masimo
MASI
+$931K
3
PDYN icon
Palladyne AI
PDYN
+$929K
4
ELS icon
Equity Lifestyle Properties
ELS
+$926K
5
BWA icon
BorgWarner
BWA
+$898K

Top Sells

Rank Stock Value
1
CG icon
Carlyle Group
CG
+$962K
2
WGS icon
GeneDx Holdings
WGS
+$933K
3
VSAT icon
Viasat
VSAT
+$852K
4
INFA
Informatica
INFA
+$807K
5
AMGN icon
Amgen
AMGN
+$804K

Sector Composition

Rank Sector Weight
1 Healthcare 17.61%
2 Technology 17.16%
3 Industrials 15.49%
4 Financials 11.59%
5 Consumer Discretionary 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OIS icon
876
Oil States International
OIS
$522M
– –
-54,342
Closed -$275K
OLMA icon
877
Olema Pharmaceuticals
OLMA
$1.02B
– –
-69,526
Closed -$405K
ONEW icon
878
OneWater Marine
ONEW
$214M
– –
-12,569
Closed -$218K
OOMA icon
879
Ooma
OOMA
$550M
– –
-10,879
Closed -$153K
ORI icon
880
Old Republic International
ORI
$10.3B
– –
-14,811
Closed -$536K
OSW icon
881
OneSpaWorld
OSW
$2.67B
– –
-22,130
Closed -$440K
OTTR icon
882
Otter Tail
OTTR
$3.88B
– –
-3,520
Closed -$260K
OWL icon
883
Blue Owl Capital
OWL
$6.39B
– –
-10,801
Closed -$251K
PAR icon
884
PAR Technology
PAR
$637M
– –
-4,703
Closed -$342K
PAY icon
885
Paymentus
PAY
$3.63B
– –
-6,290
Closed -$205K
PCRX icon
886
Pacira BioSciences
PCRX
$1.02B
– –
-23,021
Closed -$434K
PDFS icon
887
PDF Solutions
PDFS
$2.13B
– –
-10,380
Closed -$281K
PEBO icon
888
Peoples Bancorp
PEBO
$1.45B
– –
-8,043
Closed -$255K
PINS icon
889
Pinterest
PINS
$12.4B
– –
-15,657
Closed -$454K
PLOW icon
890
Douglas Dynamics
PLOW
$1.07B
– –
-12,281
Closed -$290K
PLRX icon
891
Pliant Therapeutics
PLRX
$67.5M
– –
-18,323
Closed -$241K
PLTK icon
892
Playtika
PLTK
$1.4B
– –
-37,659
Closed -$261K
PLTR icon
893
Palantir
PLTR
$295B
– –
-5,618
Closed -$425K
PM icon
894
Philip Morris
PM
$301B
– –
-2,998
Closed -$361K
PNW icon
895
Pinnacle West Capital
PNW
$12.9B
– –
-6,419
Closed -$544K
POET icon
896
POET Technologies
POET
$1.19B
– –
-20,042
Closed -$119K
POOL icon
897
Pool Corp
POOL
$6.7B
– –
-610
Closed -$208K
PPBI
898
DELISTED
Pacific Premier Bancorp
PPBI
– –
-25,690
Closed -$640K
PPC icon
899
Pilgrim's Pride
PPC
$6.82B
– –
-13,747
Closed -$624K
PRDO icon
900
Perdoceo Education
PRDO
$1.9B
– –
-8,106
Closed -$215K
34 35
36
37 38

Similar funds

SFA
Seneca Financial Advisors Rochester, New York $341M AUM 14.73% 1-Year Est. Return
FCM
Findell Capital Management New York $341M AUM 135.6% 1-Year Est. Return
CPI
Crestview Partners II New York $341M AUM 17.29% 1-Year Est. Return
SW
SMART Wealth Omaha, Nebraska $341M AUM 24.37% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return
KFSC
Keystone Financial Services (Colorado) Loveland, Colorado $341M AUM 18.11% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SC
Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return

EntryPoint Capital's Q1 2025 Portfolio in Review

As of Q1 2025, EntryPoint Capital held 1,001 positions worth $218M, down 8.2% from $238M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

EntryPoint Capital's Q1 2025 filing shows 307 new, 177 increased, 167 reduced and 349 closed positions. Its largest new stake was AtriCure: 25,168 shares worth $812K. The largest sale was Carlyle Group, an estimated $962K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

  • EntryPoint Capital's largest Q1 2025 buy was AtriCure: 25,168 shares worth $812K.
  • EntryPoint Capital added most to Amphenol in Q1 2025, an estimated $815K increase.
  • EntryPoint Capital's biggest Q1 2025 reduction was Harmony Biosciences, cutting an estimated $692K.
  • EntryPoint Capital fully exited Carlyle Group in Q1 2025, selling an estimated $962K.
  • EntryPoint Capital's ten largest holdings make up 4.4% of its $218M portfolio in Q1 2025.
  • EntryPoint Capital opened 307 new positions and closed 349 in Q1 2025.
  • EntryPoint Capital's portfolio value fell 8.2% quarter-over-quarter to $218M.

Based on EntryPoint Capital's 13F filing for Q1 2025, filed 14 May 2025.